Utility of measuring (1,3)-β-d-glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infection
about
2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis.Voriconazole treatment of Candida tropicalis meningitis: persistence of (1,3)-β-D-glucan in the cerebrospinal fluid is a marker of clinical and microbiological failure: A case report.Molecular diagnosis of invasive mycoses of the central nervous system.Translational Development and Application of (1→3)-β-d-Glucan for Diagnosis and Therapeutic Monitoring of Invasive Mycoses.Laboratory Diagnosis of Central Nervous System Infection.Current laboratory approaches to diagnosis of CNS fungal infections.Successful treatment of Aspergillus ventriculitis through voriconazole adaptive pharmacotherapy, immunomodulation, and therapeutic monitoring of cerebrospinal fluid (1→3)-β-D-glucan.Fatal Mycotic Aneurysm of the Basilar Artery Caused by Aspergillus fumigatus in a Patient with Pituitary Adenoma and Meningitis.Evaluation of the (1,3)-β-D-glucan assay for the diagnosis of neonatal invasive yeast infections.Cerebrospinal Fluid (1,3)-Beta-d-Glucan Testing Is Useful in Diagnosis of Coccidioidal Meningitis.The diagnostic performance of the beta-glucan assay in the detection of intra-amniotic infection with Candida species.Diagnostic Modalities for Invasive Mould Infections among Hematopoietic Stem Cell Transplant and Solid Organ Recipients: Performance Characteristics and Practical Roles in the Clinic.Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients.
P2860
Q30274757-8E817AF6-D66E-4212-B980-D7D50142CDDEQ30376282-A0077083-9C1F-4629-9A10-86385F739DC1Q36218994-24DDDC40-F5D9-412B-85E2-3C1B77B8A45CQ38679742-504848CD-9659-43D3-915C-0D0C8F7FCD51Q38816317-BAA93ACD-D935-4FCD-9C42-EC8B2FFB9990Q38911637-7EB1CFED-FBED-4CE1-A23E-251106AAD5E4Q39006744-91748258-E188-4A03-8BB2-AD88A55EF255Q40108892-0D18F8A8-5DCC-4C3D-852F-C4761EEF9339Q40266645-30E39A7A-0044-4C77-A0BE-58EE053B1E34Q40564160-2ECF3D90-6001-4516-9BFD-5982A09AB682Q46244075-09A7FDF8-A271-4EBA-B991-A56285716AE2Q49307735-4E15CBBB-CD80-4160-9C7B-36C4C7FB2D2CQ50072321-40621BB4-5065-4729-B6A2-FC2D3A5F02CC
P2860
Utility of measuring (1,3)-β-d-glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infection
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Utility of measuring (1,3)-β-d ...... ntral nervous system infection
@ast
Utility of measuring (1,3)-β-d ...... ntral nervous system infection
@en
Utility of measuring (1,3)-β-d ...... ntral nervous system infection
@nl
type
label
Utility of measuring (1,3)-β-d ...... ntral nervous system infection
@ast
Utility of measuring (1,3)-β-d ...... ntral nervous system infection
@en
Utility of measuring (1,3)-β-d ...... ntral nervous system infection
@nl
prefLabel
Utility of measuring (1,3)-β-d ...... ntral nervous system infection
@ast
Utility of measuring (1,3)-β-d ...... ntral nervous system infection
@en
Utility of measuring (1,3)-β-d ...... ntral nervous system infection
@nl
P2093
P2860
P356
P1476
Utility of measuring (1,3)-β-d ...... ntral nervous system infection
@en
P2093
Barbara Markley
Carlos A Pardo
Jennifer L Lyons
Kathryn A Carson
Kieren A Marr
Kiran T Thakur
Malcolm A Finkelman
Sean X Zhang
Tonya Watkins
P2860
P304
P356
10.1128/JCM.02301-14
P407
P577
2014-11-05T00:00:00Z